Cargando…
Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial
IMPORTANCE: Adenomyosis is a common chronic gynecological disorder, and its treatment is an unmet need. New therapies need to be developed. Mifepristone is being tested for adenomyosis treatment. OBJECTIVE: To determine whether mifepristone is effective and safe for adenomyosis treatment. DESIGN, SE...
Autores principales: | Che, Xuan, Wang, Jianzhang, Sun, Wenting, He, Jiayi, Wang, Qiming, Zhu, Danyang, Zhu, Weili, Zhang, Jing, Dong, Jie, Xu, Jingui, Zheng, Feiyun, Zhou, Jianwei, Zhao, Weidong, Lin, Qiao, Ye, Lingfang, Zhao, Xiumin, Xu, Zhengfen, Chen, Yunyan, Wang, Jing, Wu, Wenlie, Zhai, Lingyun, Zhou, Yuanyuan, Zheng, Jianguang, Zhang, Xinmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261993/ https://www.ncbi.nlm.nih.gov/pubmed/37307001 http://dx.doi.org/10.1001/jamanetworkopen.2023.17860 |
Ejemplares similares
-
The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea
por: Che, Xuan, et al.
Publicado: (2020) -
A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis
por: Che, Xuan, et al.
Publicado: (2019) -
Extrinsic Adenomyosis Is Associated With Postoperative Recurrence of Ovarian Endometrioma
por: Sun, Man, et al.
Publicado: (2022) -
Efficacy of the levonorgestrel-releasing intrauterine device is associated with different subtypes of adenomyosis: a retrospective study
por: Chen, Shuyi, et al.
Publicado: (2020) -
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
por: Qin, Xiaoyan, et al.
Publicado: (2021)